Amendment to Securities Purchase Agreement Between Boston Therapeutics Inc. and CJY Holdings Limited

Summary

Boston Therapeutics Inc. and CJY Holdings Limited have agreed to amend their Securities Purchase Agreement dated September 24, 2015. The amendment increases the offering amount from $750,000 to $1,050,000 and clarifies that the note will provide bridge financing until a future financing round, expected to be structured as convertible preferred stock. Upon closing of this future financing, the note will automatically convert into the new preferred stock. Both parties have signed to confirm their agreement to these changes.

EX-4.1 2 exh4_1.htm EXHIBIT 4.1 exh4_1.htm

Exhibit 4.1

Boston Therapeutics Inc.

303 East Wacker Drive, Suite 1040

Chicago, Illinois 60601

October 23, 2015

CJY Holdings Limited

12 Repulse Bay Road

Repulse Bay, Hong Kong

Re:

Securities Purchase Agreement dated September 24, 2015 (the “SPA”) by and between Boston Therapeutics Inc. and CJY Holdings Limited

Gentlemen:

Reference is hereby made to the SPA. By executing this letter, the undersigned investor agrees that the offering amount shall be increased from $750,000 to $1,050,000. Accordingly, it is hereby agreed to by the parties that Section 1(d) of the Agreement shall be amended and restated to state the following:

"d. Subsequent Financing. The Note is intended to provide necessary bridge financing to the Company prior to an anticipated financing in the near future of an amount up to $1,050,000 which is expected to be structured as convertible preferred stock (the "Preferred Financing"). Upon the closing of the Preferred Financing, the Note shall automatically convert into the Preferred Financing."

We kindly request that you execute this letter below indicating that you agree with the above amendment.

Sincerely,

Boston Therapeutics Inc.

By: /s/David Platt

Name: David Platt

Title: CEO and Director

AGREED AND ACKNOWLEDGED:

CJY Holdings Limited

By: /s/Cheng Chi Him

Name: Cheng Chi Him

Title: